TNS2
Basic information
Region (hg38): 12:53046969-53064379
Previous symbols: [ "TENC1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 70 | 82 | ||||
missense | 174 | 15 | 195 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 4 | 3 | 1 | 8 | ||
non coding | 23 | 22 | 48 | |||
Total | 0 | 0 | 186 | 108 | 37 |
Variants in TNS2
This is a list of pathogenic ClinVar variants found in the TNS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-53049172-G-C | Benign (Jan 30, 2024) | |||
12-53049215-G-A | Likely benign (Oct 31, 2022) | |||
12-53049257-C-T | TNS2-related disorder | Likely benign (Aug 30, 2023) | ||
12-53049263-T-C | Likely benign (Jul 12, 2022) | |||
12-53049265-G-C | Benign (Jan 28, 2024) | |||
12-53050220-G-A | TNS2-related disorder | Uncertain significance (Dec 29, 2023) | ||
12-53050223-C-T | TNS2-related disorder | Likely benign (Dec 20, 2022) | ||
12-53050251-C-G | Likely benign (Feb 01, 2023) | |||
12-53051866-T-G | Likely benign (Jun 11, 2022) | |||
12-53051883-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
12-53051893-T-C | TNS2-related disorder | Benign/Likely benign (Dec 27, 2023) | ||
12-53051905-A-T | Uncertain significance (May 31, 2022) | |||
12-53051920-A-G | Conflicting classifications of pathogenicity (Oct 01, 2023) | |||
12-53051939-G-A | not specified | Uncertain significance (Apr 17, 2024) | ||
12-53051970-C-T | TNS2-related disorder | Likely benign (Feb 08, 2024) | ||
12-53052175-T-C | Benign (May 15, 2021) | |||
12-53052468-G-A | TNS2-related disorder | Likely benign (Jan 27, 2023) | ||
12-53052471-G-A | TNS2-related disorder | Likely benign (Nov 30, 2022) | ||
12-53052495-G-A | Uncertain significance (Nov 04, 2023) | |||
12-53053398-G-A | Uncertain significance (Apr 07, 2023) | |||
12-53053401-C-T | TNS2-related disorder | Benign (Jan 19, 2024) | ||
12-53053404-C-T | Likely benign (Jan 12, 2024) | |||
12-53053420-G-T | Uncertain significance (Aug 21, 2022) | |||
12-53053431-C-G | Likely benign (Dec 20, 2021) | |||
12-53053441-G-A | Uncertain significance (Feb 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNS2 | protein_coding | protein_coding | ENST00000314276 | 29 | 17404 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.70e-7 | 1.00 | 125678 | 0 | 70 | 125748 | 0.000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.06 | 751 | 837 | 0.897 | 0.0000490 | 9007 |
Missense in Polyphen | 311 | 358.29 | 0.868 | 3976 | ||
Synonymous | 0.616 | 334 | 349 | 0.958 | 0.0000211 | 3013 |
Loss of Function | 4.93 | 24 | 67.8 | 0.354 | 0.00000324 | 775 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000733 | 0.000718 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000561 | 0.000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000266 | 0.000264 |
Middle Eastern | 0.000561 | 0.000544 |
South Asian | 0.000295 | 0.000294 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates cell motility and proliferation. May have phosphatase activity. Reduces AKT1 phosphorylation. Lowers AKT1 kinase activity and interferes with AKT1 signaling. {ECO:0000269|PubMed:15817639}.;
- Pathway
- EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- rvis_EVS
- -1.31
- rvis_percentile_EVS
- 4.82
Haploinsufficiency Scores
- pHI
- 0.214
- hipred
- N
- hipred_score
- 0.415
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Tns2
- Phenotype
- hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; immune system phenotype; renal/urinary system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- kidney development;protein dephosphorylation;negative regulation of cell population proliferation;response to muscle activity;cellular homeostasis;collagen metabolic process;multicellular organism growth;intracellular signal transduction;multicellular organismal homeostasis
- Cellular component
- plasma membrane;focal adhesion
- Molecular function
- phosphoprotein phosphatase activity;protein binding;kinase binding;metal ion binding